Details
Description
This poster explores the use of PCORnet®, the National Patient-Centered Clinical Research Network, for active safety surveillance of Epidiolex®, the first cannabis-derived cannabidiol (CBD) human drug product. It was presented at the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Additional Information
Contributors
Presenter(s)
Silvia Perez-Vilar